Donald W. DeGolyer - 10 Nov 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
10 Nov 2025
Net transactions value
-$187,623
Form type
4
Filing time
12 Nov 2025, 16:13:07 UTC
Previous filing
13 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DeGolyer Donald W Director 300 PROFESSIONAL DR, GAITHERSBURG /s/ Richard S. Lindahl, Attorney-in-fact 12 Nov 2025 0001583098

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $187,623 -17,801 -13% $10.54 119,858 10 Nov 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on October 2, 2025.
F2 For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.33 - $10.79. The Company maintains a record of the transactions and copies will be provided upon request.